Eran Orr: Virtual Reality Coming to ADHD

Video

A virtual reality platform could enable ADHD patients to improve cognitive functioning.

The need to leverage new technology may have never been greater in treating attention deficit/hyperactivity disorder (ADHD), especially during the coronavirus disease 2019 (COVID-19) pandemic.

Virtual reality experiences have the opportunity to really help children who are suffering from ADHD, presenting a virtual world that can help deal with some of the symptoms of the disorder.

Recently, XRHealth unveiled a new ADHD virtual reality system aimed at improving well-known ADHD cognitive functioning, including attention, impulsivity, and higher and more complex thinking functions such as initiating, organizing, planning, and fully executing daily tasks.

In the new VR system, each user is monitored for progress based on sustained focus while distractions are present.

The new system is based on the brain’s ability to restructure itself in attempt to overcome existing challenges, referred to as the brain’s plasticity principle.

Clinicians will also have the ability to create, monitor, and adjust the training process at every step within the training system.

The system contains a number of core focuses, including motor activation, a visual and auditory experience that mimics real life activity to improve motor movement, and integrated eye tracking technology.

In an interview with HCPLive®, Evan Orr, Founder and CEO of XRHealth, explained how the new virtual reality platform works and why ADHD lends itself to a virtual reality solution.

Related Videos
HCPLive Five at APA 2024 | Image Credit: HCPLive
John M. Oldham, MD: A History of Personality Disorder Pathology
Franklin King, MD: Psychedelic Therapy History, Advances, and Hurdles
Robert Weinrieb, MD: Psychiatry-Hepatology Approach for Alcohol-Related Liver Disease
Etienne Sibille, PhD: Innovations in Cognitive Pathology
Katharine Phillips, MD: Various Treatments for Obsessive-Compulsive Disorders
Manish Jha, MD: Treatment Options for Treatment-Resistant Depression
Katharine Phillips, MD: Differences Between OCD, Body Dysmorphic Disorder
Brian Barnett, MD: Psychedelics Fitting into the SUDs Treatment Paradigm
© 2024 MJH Life Sciences

All rights reserved.